Page last updated: 2024-09-05

tv3326 and rasagiline

tv3326 has been researched along with rasagiline in 6 studies

Compound Research Comparison

Studies
(tv3326)
Trials
(tv3326)
Recent Studies (post-2010)
(tv3326)
Studies
(rasagiline)
Trials
(rasagiline)
Recent Studies (post-2010) (rasagiline)
1501153572314

Protein Interaction Comparison

ProteinTaxonomytv3326 (IC50)rasagiline (IC50)
CholinesteraseHomo sapiens (human)2.3865
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.0029
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.2115
Amine oxidase [flavin-containing] AHomo sapiens (human)1.088
AcetylcholinesteraseHomo sapiens (human)0.019
Amine oxidase [flavin-containing] BHomo sapiens (human)0.2217

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chorev, M; Finberg, J; Finkelstein, N; Friedman, R; Goldenberg, W; Goren, T; Gross, A; Herzig, Y; Huang, W; Krais, B; Lavian, G; Lerner, D; Miskolczi, I; Molnar, S; Rantal, F; Razin, M; Sterling, J; Tamas, T; Toth, G; Weinstock, M; Youdim, MB; Zagyva, A; Zekany, A1
Binda, C; Edmondson, DE; Herzig, Y; Hubálek, F; Li, M; Mattevi, A; Sterling, J; Youdim, MB1
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V1
Huang, L; Jiang, H; Li, X; Lu, C; Luo, Z; Mao, F; Shan, W; Su, T; Sun, Y1
Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J1
Affini, A; Hagenow, S; Lutsenko, K; Reiner, D; Stark, H1

Reviews

2 review(s) available for tv3326 and rasagiline

ArticleYear
Multi-target-directed ligands to combat neurodegenerative diseases.
    Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid

2008
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
    Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20

    Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands

2019

Other Studies

4 other study(ies) available for tv3326 and rasagiline

ArticleYear
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Journal of medicinal chemistry, 2002, Nov-21, Volume: 45, Issue:24

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Carbamates; Cattle; Cholinesterase Inhibitors; Humans; Indans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Propylamines; Structure-Activity Relationship

2002
Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Alkynes; Circular Dichroism; Humans; Indans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Structure-Activity Relationship

2004
Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
    Journal of medicinal chemistry, 2012, Oct-11, Volume: 55, Issue:19

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Antioxidants; Benzylidene Compounds; Cations, Divalent; Chelating Agents; Copper; Humans; Indans; Iron; Isoenzymes; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Peptide Fragments; Recombinant Proteins; Structure-Activity Relationship; Zinc

2012
Rasagiline derivatives combined with histamine H
    Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19

    Topics: Histamine H3 Antagonists; Humans; Indans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Histamine H3

2019